多期与单期胸腹开窗腔内主动脉修复的技术要点与结局
这项回顾性双中心研究纳入2015至2022年87例连续接受胸主动脉腔内修复(TEVAR)联合择期开窗修复(FEVAR,开窗Anaconda装置)的患者,比较单期(n=61)与两期(n=26)策略。两期间脊髓缺血率和严重程度无差异,两期组入路并发症更高(23% vs 7%,p=0.027),30天死亡率无显著差异(单期4.6% vs 两期3.8%,p=0.083)。作者认为联合术式可行安全,单期策略在Crawford IV、V型或近肾动脉瘤中可行,长段覆盖和高ASA分级者推荐两期修复。
要点
- TEVAR联合FEVAR(开窗Anaconda装置)在胸腹主动脉瘤和近肾动脉瘤中可行且安全。
- 两期组入路并发症高于单期组(23% vs 7%,p=0.027),脊髓缺血率无差异。
- 作者推荐长段主动脉覆盖和高ASA分级者采用两期修复。
核心结论
- TEVAR联合FEVAR使用开窗支架可行且安全,主动脉形态在腔内修复后无显著变化。
- 单期策略在Crawford IV型、Crawford V型或近肾动脉瘤中可行且结果优良。
- 作者推荐长段主动脉覆盖和较高ASA分级者采用两期修复。
- 需要随访数据评估TEVAR/FEVAR连接处的长期稳定性。
研究设计与样本
- 回顾性双中心研究,纳入2015至2022年87例连续接受TEVAR联合择期FEVAR(开窗Anaconda装置)的患者。
- 比较单期(1S,n=61)与两期(2S,n=26)干预,记录基础病变、主动脉形态、技术细节和术后并发症。
主要发现
- 适应症为胸腹主动脉瘤(TAAA,Crawford I-IV型)(n=56,64%)和近肾动脉瘤(n=31,36%)。
- 两期组TAAA比例高于单期组(2S:77% vs 1S:59%;p=0.001)。
- 两期组降主动脉覆盖长度更长(1S:128±60 mm vs 2S:202±64 mm;p=0.003)。
- 临时瘤囊灌注(TASP)在单期组11例(18%)和两期组1例(4%)中建立(p=0.079),脑脊液引流管在单期组48例(79%)和两期组19例(73%)中放置。
- 脊髓缺血率和严重程度两组无差异,共3例持续性截瘫;两期组入路并发症高于单期组(n=6,23% vs n=4,7%;p=0.027)。
临床怎么用
- 作者认为单期策略在Crawford IV型、Crawford V型或近肾动脉瘤中可行且结果优良。
- 作者推荐长段主动脉覆盖和较高ASA分级者采用两期修复。
- 作者指出需要随访数据评估TEVAR/FEVAR连接处的长期稳定性。
局限性
- 需要随访数据评估TEVAR/FEVAR连接处的长期稳定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In some cases of endovascular thoracoabdominal or juxtarenal aortic aneurysm repair, a thoracic endograft in combination with a fenestrated renovisceral device may be needed in order to create a sufficient proximal landing zone. This study aimed to evaluate the technical aspects and postoperative morbidity of a single- or 2-stage approach. METHODS: Eighty-seven consecutive patients undergoing thoracic endovascular aortic repair (TEVAR) in combination with elective fenestrated repair (fenestrated endovascular aortic repair [FEVAR]; fenestrated Anaconda device) from 2015 to 2022 were included in this retrospective bicentric study. Underlying pathologies, aortic morphology, technical details, and postoperative morbidity were recorded. RESULTS: Single-staged ("1S," n=61) and 2-staged ("2S," n=26) interventions were compared. Indications were thoracoabdominal aneurysms (TAAAs) (Crawford I-IV) (n=56, 64%) and juxtarenal aneurysms (n=31, 36%). In 2S, the proportion of TAAA was higher than in 1S (2S: 77%, 1S: 59%; p=0.001). In 2S, the covered length of the descending aorta was longer (1S: 128±60 mm, 2S: 202±64 mm; p=0.003). Temporary aneurysm sack perfusion (TASP) was established in 11 (18%) of 1S and 1 (4%) of 2S patients (p=0.079), as well as cerebrospinal fluid (CSF) drainage catheter in 48 (79%) of 1S and 19 (73%) of 2S. The rate of spinal cord ischemia (SCI) and the severity of SCI were not different in both groups, with a total of 3 cases of persisting paraplegia. The rate of access complications was higher in 2S (n=6, 23%) than in 1S (n=4, 7%; p=0.027). Postoperative 30 day morbidity did not significantly differ in both groups and neither did 30 day mortality (4.6% in 1S vs 3.8% in 2S; p=0.083). CONCLUSION: The combination of TEVAR and FEVAR using a fenestrated endograft is feasible and safe. Aortic morphology does not change significantly after endovascular repair. A single-staged strategy is feasible with excellent results, especially in Crawford IV, Crawford V, or juxtarenal aneurysms. Two-staged repair is recommended in cases with long aortic coverage and a higher American Society of Anesthesiologists (ASA) class. Follow-up data are needed to evaluate the long-term stability of the TEVAR/FEVAR interconnection.Clinical impactOur study has revealed the safety and efficacy of the combination of TEVAR and FEVAR in the treatment of TAAAs and juxtarenal aneurysms with compromised supravisceral landing zones. A single-staged concept is not necessary in all cases. Staged procedures may reduce postoperative morbidity in cases with long aortic coverage and higher ASA class.
引用
- Frese JP, Walter C, Carstens J, et al. Technical Aspects and Outcome of Multi-Staged and Single-Staged Thoracoabdominal Fenestrated Endovascular Aortic Repair. J Endovasc Ther. 2024. PMID: 38804508. doi:10.1177/15266028241255533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。